Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,556 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05371483Enrolling by invitation
Study effects of narcolepsy and hypersomnia treatments on brain and heart
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
Scottsdale, ArizonaAges 18–75 - NCT05352139Enrolling by invitation
TenJet treatment for chronic tendon pain
This trial studies a device (TenJet hydroresection) used to treat long-lasting tendon pain by targeting damaged tendon tissue. It may help people whose tendon pain has not improved after several months of non-surgical care.
Redwood City, CaliforniaAges 18–70 - NCT05336188Enrolling by invitation
Smartphone help to prevent relapse in opioid use disorder
This study looks at whether a smartphone-based program can help people avoid relapse from opioid use disorder. Some participants may also do brain scans to better understand the brain changes behind relapse prevention.
Little Rock, ArkansasAges 18 years+ - NCT05301361Enrolling by invitationPhase 1
Test of brain testing during stimulant treatment for ADHD
This trial checks whether a “NIH Toolbox” set of child-friendly tests can detect changes when stimulant medicine is used for ADHD. It may help doctors better measure how well stimulant treatment is working in people with intellectual disability.
Sacramento, CaliforniaAges 6–24 - NCT05248919Enrolling by invitation
Study treatment for hepatitis C that did not work before
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
Karachi, SindhAges 18–100 - NCT05248659Enrolling by invitationPhase 2/Phase 3
Sibeprenlimab for IgA kidney disease after prior study
This trial studies sibeprenlimab to see if it can improve IgA nephropathy, a kidney inflammation condition. You may be able to join if you finished a previous related Otsuka study without major safety problems and your doctor thinks you could benefit.
Birmingham, AlabamaAges 18 years+ - NCT05233111Enrolling by invitation
Exposure therapy to reduce PTSD after spinal cord injury
This trial compares a specific type of talk therapy (brief prolonged exposure) versus standard care to reduce post-traumatic stress symptoms after a spinal cord injury. If you qualify, you may get extra support targeted at PTSD symptoms during inpatient rehab.
Dallas, TexasAges 18 years+ - NCT05231993Enrolling by invitation
Treats HPV-positive atypical cervical cells found on screening
This study is for women whose cervical screening shows atypical glandular cells and who test positive for HPV types 16 or 18. It aims to decide the best way to triage and manage these findings so people get the right follow-up and treatment.
StockholmAges 23–64 - NCT05195944Enrolling by invitationPhase 4
Semaglutide versus sitagliptin after liver transplant for diabetes
This trial compares two diabetes medicines—semaglutide and sitagliptin—in people who have had a liver transplant and have type 2 diabetes (or diabetes after transplant). It’s looking to see which medicine works better and is safe for blood sugar control in the transplant setting.
Toronto, OntarioAges 18 years+ - NCT05195515Enrolling by invitation
Study on bladder cancer late effects and quality of life
This study looks at how long-term (late) effects after bladder cancer treatment affect quality of life. You may join if you recently had blood in your urine and are being evaluated for it in a specific region of Denmark.
Aarhus NAges 18 years+ - NCT05159960Enrolling by invitation
Repeat laser eye treatment study for eligible prior participants
This study is for people who already joined an earlier selective laser eye treatment trial and were able to be followed without needing stronger additional treatments. It looks at the best plan for repeating the laser treatment when appropriate.
Skövde, Västra Götaland CountyAges 18 years+ - NCT05127954Enrolling by invitationPhase 3
Long-term migraine tablet study for kids and teens ages 6–17
This study follows kids and teens who already took part in an earlier migraine medication study to check long-term safety and comfort with oral ubrogepant tablets. It may help families understand whether this migraine tablet is safe to keep using over time.
Huntsville, AlabamaAges 6–17 - NCT05122325Enrolling by invitation
Treatment to improve sexual function after spinal cord injury
This trial looks for a treatment that can improve sexual problems in women whose spinal cord injury has partially affected sensation and function. You may be able to join if you are not in menopause and your sexual difficulty started after your injury and has lasted at least 12 months.
Toledo, ToledoAges 18–60 - NCT05115877Enrolling by invitation
Looking back at treatment outcomes for stomach or gut diseases
This study looks at past care for adults who had non-cancer or cancer of the gastrointestinal (stomach and intestines) tract and compares treatment outcomes. It may help improve how doctors manage these conditions in the future.
Richardson, TexasAges 18 years+ - NCT05033457Enrolling by invitation
Compare two treatments for lumbar spinal canal narrowing
This trial compares two approaches (UBE and PETD) for relieving nerve pressure caused by a single-level problem in the lower spine. It may help reduce pain and nerve symptoms by treating the narrowed spinal canal or disc-related compression.
Taiyuan, ShanxiAges Any age - NCT04879121RecruitingPhase 2
Larotrectinib for tumors with extra NTRK gene copies
This trial studies larotrectinib, a targeted medicine, in people with solid tumors that have extra copies (amplification) of the NTRK1, NTRK2, or NTRK3 gene. It’s for cancers that have already been treated with standard options or where standard options are unlikely to help.
Houston, TexasAges 16 years+ - NCT04875078Enrolling by invitation
UVA-1 light treatment for hand skin tightness in scleroderma
This study tests whether UVA-1 light sessions can loosen tight skin and improve hand function in people with scleroderma. If you qualify, you would attend UVA-1 treatments twice a week for the study period.
Murray, UtahAges 18 years+ - NCT04847648Enrolling by invitation
Air polishing for gum infection around dental implants
This trial tests whether “air polishing” (a gentle cleaning method) can improve peri-implantitis, an infection and inflammation around dental implants. It may help by reducing deep gum pockets, bleeding, pus, and bone loss around the implant.
GothenburgAges 18 years+ - NCT04833907Enrolling by invitationPhase 1/Phase 2
Gene therapy study for typical Canavan disease in children
This early-phase trial tests a gene therapy medicine (delivered by a one-time infusion) for children with typical Canavan disease. It aims to improve safety and help evaluate whether the treatment may benefit children over time.
Dayton, OhioAges 3 months–5 years - NCT04805957Enrolling by invitation
Check brain and behavior markers during sulforaphane in autism
This study tests whether “digital biomarkers” (measurable signs from digital devices) change during treatment with sulforaphane, which is found in certain broccoli extracts. It may help researchers better understand which signals track response in young men with autism.
Piscataway, New JerseyAges 13–30 - NCT04762992Enrolling by invitationPhase 3
Heparin medicine for early slow fetal growth in one pregnancy
This study tests whether a blood-thinner medicine (LMWH) can improve outcomes for people carrying a singleton baby with early signs of slow growth. It compares LMWH against standard care to see if treatment helps the baby and pregnancy stay safer.
LisbonAges 18 years+ - NCT04762459Enrolling by invitationPhase 3
Almonertinib after lung tumor surgery, with or without chemo
This study tests whether almonertinib taken after complete surgery can improve outcomes for people with stage II–IIIA non-small cell lung cancer (NSCLC) that has certain EGFR gene changes. It also compares almonertinib plus chemotherapy versus almonertinib alone to see which approach is safer and works better.
Beijing, Beijing MunicipalityAges 18–130 - NCT04712318Enrolling by invitation
Treatment for lingering blurry vision after trifocal lens
This study tests a treatment to improve vision in people who still have an ongoing focusing problem (residual nearsightedness or farsightedness) about 6 months after receiving a trifocal intraocular lens. It may help if your vision is still reduced despite having the lens implanted.
PristinaAges 20–45 - NCT04693663Enrolling by invitation
Relex-SMILE treatment for leftover nearsightedness after cataract surgery
This trial tests whether Relex-SMILE eye laser surgery can improve nearsightedness that remains after you’ve already had cataract surgery. It’s meant for people with a certain range of leftover nearsightedness, while excluding certain eye problems and prior eye procedures.
PristinaAges 20–70
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,556 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.